Publications by authors named "A E Goncharov"

TiZrMoC coatings were deposited on Si(100) substrates using a DC dual magnetron sputtering. The composition was controlled by adjusting the sputtering parameters of the TiZrMo and graphite targets. The influence of graphite target current on the resulting coating properties was explored.

View Article and Find Full Text PDF

High-energy-density materials (HEDMs) are crucial in various applications, from energy storage to defense technologies. Transition metal polynitrides are promising candidates for HEDMs. Using single-crystal synchrotron X-ray diffraction, we investigated the crystal structures of niobium nitride, specifically NbN and NbN, under high-pressure conditions of up to 86 GPa.

View Article and Find Full Text PDF
Article Synopsis
  • - Patients with non-alcoholic fatty liver disease (NAFLD) show impaired nutritional habits, and certain dietary patterns like the Mediterranean, vegetarian, and DASH diets can help prevent the disease.
  • - The study involved analyzing the diets of 613 Russian patients with NAFLD and a control group, using data collected from 2021 to 2023, including assessment of liver conditions through advanced imaging techniques.
  • - Findings revealed significant differences in food intake between NAFLD patients and healthy individuals, with NAFLD patients consuming less dairy, legumes, healthy fats, fish, vegetables, and nuts, while consuming more meat, compared to recommended dietary patterns.
View Article and Find Full Text PDF

Objective: Transcatheter mitral valve interventions (TMVI) have been proven to reduce symptom burden and improve outcomes in patients with severe mitral regurgitation (MR). However, the impact of right ventricular function (RVF) on exercise capacity in MR patients is less well understood.

Methods: Cardiopulmonary exercise testing (CPET) is the most comprehensive approach to assess maximum exercise capacity.

View Article and Find Full Text PDF

Introduction: There is no consensus on the optimal concentration of lipoprotein(a) (Lp(a)) for the risk of atherosclerotic cardiovascular diseases (ASCVD) and aortic valve stenosis. In various clinical guidelines and agreed documents, the threshold level of Lp (a) is 30 mg/dl or 50 mg/dl. We estimated the cut-off value of Lp (a) associated with the risk of developing various localizations of atherosclerosis for the Central Asia, including Kazakhstani population.

View Article and Find Full Text PDF